REGISTERED NUMBER: 08142934 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

DR. SILLIFANT AND ASSOCIATES LTD.

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

Doctor K L Sillifant

REGISTERED OFFICE:

Low Farm

New Road

Fritton

Great Yarmouth

Norfolk

NR31 9HT

REGISTERED NUMBER:

08142934 (England and Wales)

ACCOUNTANTS:

Juler Tooke

Lothing House

Quay View Business Park

Barnards Way

Lowestoft

Suffolk

NR32 2HD

FIXED ASSETS

Tangible assets

4

36,487

37,204

CURRENT ASSETS

Debtors

5

58,229

16,982

Cash at bank and in hand

24,219

69,587

82,448

86,569

CREDITORS

Amounts falling due within one year

6

(18,609

)

(21,546

)

NET CURRENT ASSETS

63,839

65,023

TOTAL ASSETS LESS CURRENT LIABILITIES

100,326

102,227

PROVISIONS FOR LIABILITIES

7

(3,465

)

(2,837

)

NET ASSETS

96,861

99,390

CAPITAL AND RESERVES

Called up share capital

8

100

100

Retained earnings

9

96,761

99,290

SHAREHOLDERS' FUNDS

96,861

99,390

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 September 2026 and were signed by:

Doctor K L Sillifant - Director

1.	STATUTORY INFORMATION

Dr. Sillifant And Associates Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

20% on reducing balance, 15% on reducing balance and 10% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 January 2025

54,763

Additions

5,526

At 31 December 2025

60,289

DEPRECIATION

At 1 January 2025

17,559

Charge for year

6,243

At 31 December 2025

23,802

NET BOOK VALUE

At 31 December 2025

36,487

At 31 December 2024

37,204

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

£

Trade debtors

22,606

16,982

Other debtors

35,623

-

58,229

16,982

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

£

Trade creditors

12,321

8,481

Taxation and social security

6,288

5,866

Other creditors

-

7,199

18,609

21,546

7.	PROVISIONS FOR LIABILITIES

31.12.25

31.12.24

£

£

Deferred tax

3,465

2,837

Deferred

tax

£

Balance at 1 January 2025

2,837

Provided during year

628

Balance at 31 December 2025

3,465

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.12.25

31.12.24

value:

£

£

100

Ordinary

£1

100

100

9.

RESERVES

Retained

earnings

£

At 1 January 2025

99,290

Profit for the year

29,471

Dividends

(32,000

)

At 31 December 2025

96,761

10.	ULTIMATE CONTROLLING PARTY